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A dual antibody probing technique that permitted a color-coded identification of polypeptides representing
different classes of Epstein-Barr virus (EBV) antigens as well as differentiation of the polypeptides induced by
different herpesviruses in the same Western blot was developed. When the nitrocellulose sheet was probed first
with monoclonal antibody against EBV early antigen diffuse component (EA-D) and then stained with
4-chloro-1-naphthol, four polypeptides specific for EA-D were identified by purple bands. Subsequently, the
same nitrocellulose sheet was reprobed with human serum containing antibodies against EBV early antigen,
viral capsid antigen, and nuclear antigen and stained with 3,3'-diaminobenzidine. Several brown bands
corresponding to early, viral capsid, and nuclear antigen polypeptides were detected. The dual antibody
probing technique was used in an analysis to differentiate polypeptides resulting from either EBV or herpes
simplex virus infection, either in cells infected by individual virus or in a cell line dually infected by both
viruses. On the basis of different colored bands in different lanes of the same gel, 20 polypeptides with
molecular weights ranging from 31,000 to 165,000 were identified as herpes simplex virus-specific proteins.
These results suggested that the dual antibody probing technique may be applicable in clinical diagnosis for
detecting antigens and antibodies derived from different pathogens.
Recently we demonstrated the feasibility and usefulness of
a Western blotting enzyme-linked immunosorbent technique
in the qualitative and quantitative analyses of polypeptides
induced by Epstein-Barr virus (EBV) (1). We developed a
rapid immunochemical method that allows sequential analy-
sis and detection of different antigens induced by EBV and
herpes simplex virus (HSV) by using dual antibody probes.
An advantage of this method is that it can identify the
polypeptides representing different classes of EBV antigens
and also differentiate the antigens resulting from EBV or
HSV infection.
The propagation of human lymphoblastoid cell lines and
superinfection of Raji cells were described elsewhere (2, 3).
Preparation of whole-cell extracts and Western blotting of
the separated proteins after sodium dodecyl sulfate-polyacry-
lamide gel electrophoresis were described previously (1).
To identify the polypeptides representing different classes
of antigen in EBV-infected cells, the nitrocellulose sheet of
the Western blot was sequentially probed by reacting with
different antibodies. When the sheet was first reacted with
monoclonal antibody to early antigen diffuse component
(EA-D) by using 4-chloro-1-naphthol as a substrate,
polypeptides representing EA-D were identified by purple
bands. As reported before (1), a family of four polypeptides
with molecular sizes of 46,000, 49,000, 52,000, and 55,000
daltons were expressed in superinfected Raji cells (Fig. 1,
lane C, purple bands) but not in mock-infected Raji cells
(Fig. 1, lane B), in BJAB (an EBV-negative cell line; Fig. 1,
lane A), or in four different cord blood lymphocyte cell lines
(Fig. 1, lanes D, E, F, and G) transformed by EBV derived
from throat washings of patients with infectious mononucle-
osis.
* Corresponding author.
Since Raji cells and transformed cord blood lymphocytes
contain EBV DNA and express EBV nuclear antigen
(EBNA), the same nitrocellulose sheet was reprobed by
human early antigen-positive (EA'), viral capsid antigen-
positive (VCA+), EBNA+ serum (titers, 1,200:2,500:640)
and subsequently stained with 3,3'-diaminobenzidine, which
developed brown bands (Fig. 1). Both mock-infected Raji
cells (Fig. 1, lane B) and superinfected Raji cells (Fig. 1, lane
C) expressed a 68,000-molecular-weight EBNA polypeptide
(68K polypeptide). In contrast, different cord blood lympho-
blastoid cell lines expressed a variety of EBNA species with
a predominant molecular weight of 78,000 (Fig. 1, lanes D,
F, and G) and a 76K and 80K doublet (Fig. 1, lane E). In
addition, some minor bands around 72K were detectable in
lanes E, F, and G. No EBNA polypeptide was detected in
BJAB cells (Fig. 1, lane A) or in untransformed cord blood
lymphocytes (Fig. 1, lane H). Additional polypeptides
(200K, 135K, 110K, 90K, 78K, and 63K) were detected in
superinfected Raji cells (Fig. 1, lane C).
The same procedures were used to differentiate antigens
induced by different herpesvirus infections. For instance,
cell extracts derived from HSV-infected Vero cells and from
the EBV-producing cell line P3HR-1 were subjected to
electrophoresis in polyacrylamide gels and were Western
blotted onto a nitrocellulose sheet. The sheet was first
reacted with human serum with EA-VCA-EBNA antibody
titers and then incubated with a peroxidase-conjugated sec-
ond antibody, and the antigenic bands were revealed by
staining with 4-chloro-1-naphthol (purple color). Several
purple bands specific for EBV-induced polypeptides were
observed (Fig. 2, lanes C and D). Two polypeptides with
molecular weights above 135,000 were partially inhibited by
acyclovir (Fig. 2, lane D), as reported previously (3).
Only a single EBNA polypeptide (68K) was detected in
the hybrid cell line D98/Raji (Fig. 2, lane A). The same
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FIG. 1. Simultaneous detection of different classes of EBV-
induced polypeptides by dual antibody probes. The nitrocellulose
sheet was saturated with protein by incubating for 1 h at 37°C in
blocking solution containing phosphate-buffered saline solution (pH
7.4), 3% bovine serum albumin, and 10%o heat-inactivated calf
serum. The sheet was then incubated for 1 h at 37°C with monoclo-
nal EBV EA-D antiserum, followed by washing in phosphate-
buffered saline four times, 15 min each time. The final incubation
was for 2 h at room temperature in rabbit anti-mouse immunoglob-
ulin G conjugated with peroxidase (Miles Laboratories, Inc.,
Elkhart, Ind.). After the sheet was again washed as described
above, antigenic bands were stained in 4-chloro-1-naphthol (60 mg in
20 ml of ice-cold methanol), 0.015% H202, and 100 ml of TBS buffer
(20 mM Tris hydrochloride [pH 7.5], 0.5 M NaCI). Purple bands
appeared within 20 min after incubation of the mixture at room
temperature in the dark. The same nitrocellulose sheet was reprobed
with human serum with antibody titers against EA, VCA, and
EBNA. The sheet was first soaked in buffer A, containing 10 mM
Tris hydrochloride (pH 7.0), 50 mM NaCl, 2 mM sodium EDTA, 4
M urea, and 0.1 mM dithiothreitol, for 30 min at room temperature.
The sheet was then treated with blocking solution for 1 h, followed
by reaction with human serum containing EA, VCA, and EBNA
antibodies. The sheet was then washed with phosphate-buffered
saline as described above. The sheet was then incubated for 2 h at
room temperature with goat anti-human immunoglobulin G conju-
gated with peroxidase. Antigenic bands were then revealed by
staining with a different substrate, 3,3'-diaminobenzidine (Sigma
Chemical Co., St. Louis, Mo.) (1 mg/ml in dimethyl sulfoxide), in 50
mM Tris hydrochloride (pH 7.5) containing 0.015% H202. Brown
FIG. 2. Identification of EBV- and HSV-induced polypeptides
by dual antibody probes. The nitrocellulose sheet of the Western
blot was first probed by HSV-specific antibody and stained with
brown color substrate. Brown bands represent HSV-specific
polypeptides (lane B). Subsequently, the same nitrocellulose sheet
was probed by EBV-specific antibody, and the antigenic bands were
stained with purple color substrate. Lane A, D98/Raji, a somatic
hybrid cell line; lane B, HSV-1 infected Vero cells; lanes C and D,
P3HR-1 in the absence and presence of the antiviral drug acyclovir,
respectively.
nitrocellulose sheet, after soaking in buffer A (10 mM Tris
hydrochloride [pH 7.0], 50 mM NaCl, 2 mM sodium EDTA,
4 M urea, 0.1 mM dithiothreitol) for 30 min, was reprobed
with HSV type 1-specific antiserum (DAKO Corporation,
Santa Barbara, Calif.), followed by peroxidase-conjugated
second antibody, and was stained with 3,3'-diamino-
bands developed after a few minutes. Lanes: A, BJAB, an EBV-
negative cell line; B, mock-infected Raji cells; C, superinfected Raji
cells; D, E, F, and G, four different EBV-transformed cord blood
cell lines; H, untransformed cord blood lymphocytes. Antiserum
had EA, VCA, and EBNA titers of 1,200, 2,500, and 640, respec-
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FIG. 3. Differentiation of EBV and HSV polypeptides expressed
in dually infected P3HR-1 cells. HSV-induced polypeptides (indi-
cated by arrowheads; brown in original) were identified by probing
with HSV-specific antiserum, whereas 49K and 46K polypeptides
(indicated by arrows; purple in original) were EBV-induced EA-D
components identified by probing with monoclonal antibody against
EA-D. Days after 12-0-tetradecanoyl-phorbol-13-acetate (TPA) in-
duction are shown above lanes.
benzidine (brown color) as described above. At least 20
polypeptides with molecular weights ranging from 31,000 to
165,000 were detectable in HSV-infected Vero cells by using
HSV-specific antiserum (Fig. 2, lane B, brown bands). These
HSV-induced polypeptides were not detected in the EBV-
producing cell line (P3HR-1) grown in the absence (Fig. 2,
lane C) and presence (Fig. 2, lane D) of the antiviral drug
acyclovir or in a somatic cell hybrid line, D98/Raji (Fig. 2,
lane A). These results clearly indicate that there was no
cross-reactivity between HSV- and EBV-induced
polypeptides in the antisera used.
In a separate experiment, we intended to differentiate
EBV and HSV polypeptides expressed in a human lympho-
blastoid cell line, P3HR-1, dually infected with both EBV
and HSV (4). Expression of resident EBV genomes in the
dually infected P3HR-1 cells was induced by 12-O.
tetradecanoyl-phorbol-13-acetate. The kinetics of EA-D syn
thesis in this cell line after 12-O-tetradecanoyl-phorbol-13-
acetate induction are shown in Fig. 3. The nitrocellulose
sheet of the Western blot was first probed with an EBV
monoclonal antibody against EA-D, and the antigenic bands
were located by purple-colored substrate. Before induction,
the dually infected P3HR-1 cells expressed predominantly a
49K polypeptide (zero time). When cells were exposed to
12-0-tetradecanoyl-phorbol-13-acetate, synthesis of the 49K
polypeptide increased with the time of induction and reached
its maximum between days 5 and 7. In parallel with the
increase in synthesis of the 49K polypeptide, a 46K poly-
peptide was induced on day 1 and thereafter. To identify the
HSV-induced polypeptides, the same nitrocellulose sheet of
Fig. 3 was subsequently probed with HSV-specific anti-
serum, and the antigenic bands were stained brown (Fig. 3,
arrowheads). At least five polypeptides were detectable
under these conditions. The expression of these
polypeptides increased with time of induction; the maximum
synthesis was on day 5.
It should be noted that in the dually infected P3HR-1 cells,
less than 1% of the cell population became productively
infected (4), compared with the majority of Vero cells
lytically infected by HSV. Besides, the presence of EBV
genomes in these cells may interefere with HSV gene
expression. Thus, the fact that fewer polypeptides were
detected in dually infected P3HR-1 cells (Fig. 3) than in
HSV-infected Vero cells (Fig. 2) is not because of the
limitation of the technique, but because of the different cell
systems.
The dual antibody probe method has a high level of
specificity and sensitivity, evidenced by a clear distinction of
EBV- and HSV-induced polypeptides in the same lane of the
same gel (Fig. 3) or in different lanes (Fig. 2, lanes B, C, and
D). The technology presented here combines convenience
and simplicity in the rapid visualization and identification of
polypeptides induced by different herpesviruses. Since si-
multaneous active infection with two or three different
herpesviruses in the same patient is not unusual in immuno-
compromised hosts, this technique has practical utility. The
method should be valuable for the routine medical diagnosis
of states of viral infection and for detection of antibodies in
pathological human sera and can yield information regarding
the type specificity of the antibody. By using different
antibody probes simultaneously with different combinations
of peroxidase substrates, it should be possible to detect the
presence of several pathogens in patients with acute infec-
tions expeditiously.
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